| Net Cash Provided by (Used in) Operating Activities |
$-198,860 |
USD |
71% |
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Financing Activities |
$460,000 |
USD |
|
Q1 2024 |
Q1 2024 |
| Net Cash Provided by (Used in) Investing Activities |
$-90,000 |
USD |
|
Q1 2024 |
Q1 2024 |
| Common Stock, Shares Authorized |
100,000,000 |
shares |
0% |
Q3 2024 |
Q3 2024 |
| Common Stock, Shares, Issued |
4,762,500 |
shares |
0% |
Q3 2024 |
Q3 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$-683,346 |
USD |
-992.5% |
Q1 2023 |
Q1 2023 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$16,415 |
USD |
-96.7% |
Q3 2024 |
Q3 2024 |
| Deferred Tax Assets, Valuation Allowance |
$356,963 |
USD |
184% |
Q4 2023 |
FY 2023 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q3 2024 |
Q3 2024 |
| Deferred Tax Assets, Gross |
$356,962 |
USD |
184% |
Q4 2023 |
FY 2023 |
| Preferred Stock, Shares Authorized |
1,000,000 |
shares |
0% |
Q3 2024 |
Q3 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2024 |
Q3 2024 |